1. Adverse effects on valproate: number of participants experiencing each event.
Event | Callaghan 1982 | Sato 1982 | Martinovic 1983 | Coppola 2004 | Huang 2009 | Glauser 2013 |
Acute pancreatitis | 1 | |||||
Obesity/Weight gain | 1 | 1 | 14 | |||
Drowsiness | 4 | |||||
Nausea | 5 | 3 | 12* | |||
Vomiting | 1 | 2 | 12* | |||
Decreased platelet numbers | 2 | 4 | ||||
Increased appetite | 15 | |||||
Poor appetite | 1 | 8 | ||||
Diarrhoea | 1 | 7 | ||||
Dizziness | 1 | 2 | ||||
Hyperactivity | 23 | |||||
Attention problems | 24 | |||||
Hostility | 22 | |||||
Concentration decreased | 18 | |||||
Personality change | 17 | |||||
Sleep problem | 17 | |||||
Depression | 11 | |||||
Slow process speed | 11 | |||||
Memory problem | 10 | |||||
Apathy | 9 | |||||
Fatigue | 27 | |||||
Headache | 1 | 18 | ||||
Leukopenia | 2 | |||||
Elevated liver function tests | 1 | 7 | ||||
Elevated LDH | 1 | |||||
Rash | 2 |
* Nausea, vomiting, or both LDH: lactate dehydrogenase
Numbers of individuals within each study undertaking valproate: 14 (Callaghan 1982), 22 (Sato 1982), 10 (Martinovic 1983), 19 (Coppola 2004), 23 (Huang 2009), 146 (Glauser 2013a).